SEMAGLUTIDE
Semaglutide (GLP-1) is a synthetic long-acting glucagon-like peptide-1 receptor agonist. It is used to study incretin signaling, glucose-dependent insulin regulation, and metabolic pathways.
Purity >99.80%Form Lyophilized PowderNo Endotoxins
Notify me when back in stock
Related Products
Peer-Reviewed Literature
Related Studies
Peer-Reviewed Literature
Related Studies
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT Trial)
New England Journal of Medicine
Landmark trial of 17,604 patients showed semaglutide 2.4 mg weekly reduced major adverse cardiovascular events by 20% in non-diabetic patients with obesity over 39.8 months.
Semaglutide and Cardiovascular Outcomes in Patients With Type 2 Diabetes (SUSTAIN-6)
New England Journal of Medicine
104-week trial in 3,297 high-risk T2DM patients showed semaglutide reduced composite MACE by 26% versus placebo — establishing cardiovascular benefit for GLP-1 receptor agonists.
Oral Semaglutide and Cardiovascular Outcomes in Patients With Type 2 Diabetes (PIONEER 6)
New England Journal of Medicine
Demonstrated cardiovascular safety of oral semaglutide 14 mg daily versus placebo in 3,183 high-risk T2DM patients, with trend toward all-cause mortality reduction.
Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1)
New England Journal of Medicine
68-week trial of 1,961 adults showed semaglutide 2.4 mg weekly achieved 14.9% mean body weight loss versus 2.4% with placebo, establishing landmark weight management efficacy.
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (SUSTAIN-6)
New England Journal of Medicine
In 3,297 patients with T2D, semaglutide reduced major adverse cardiovascular events by 26% versus placebo over 2.1 years (HR 0.74), driven by 39% stroke reduction and 26% nonfatal MI reduction.
Two-Year Effects of Semaglutide in Adults with Overweight or Obesity (STEP 5)
Nature Medicine
Participants receiving semaglutide 2.4 mg weekly maintained 15.2% body weight loss at 104 weeks, with significant improvements in cardiometabolic risk factors including waist circumference and HbA1c.
SEMAGLUTIDE FAQ
Where do I buy semaglutide online for research?
Blank Peptides lists semaglutide in 10mg, 20mg and 30mg vials, made in our cGMP labs in the USA. Each ships with a certificate of analysis tied to its lot number, readable before checkout. This is research grade material sold to researchers, so no prescription is involved. Processing time is within 1 business day.
What is semaglutide?
Semaglutide is a long-acting GLP-1 receptor agonist peptide, structurally a modified analogue of native GLP-1 with a fatty acid chain that extends its half-life through albumin binding. The pharmacology literature has characterised its receptor selectivity and signalling behaviour in detail. We supply it as a laboratory reference compound and nothing else.
What purity is your semaglutide, and is there a COA?
Greater than 99%. Every lot is assayed by HPLC and mass spectrometry at our lab, then independently confirmed at Freedom Diagnostics or Horizon Analytical, with bacterial endotoxin testing on the batch. The linked COA is lot-specific. GLP-1 analogues are a category where verification matters, so the paperwork is published rather than available on request.
How much bacteriostatic water for semaglutide 10mg?
1mL, giving 10mg/mL. The 20mg vial takes 2mL and the 30mg takes 3mL, our per-vial ceiling, so every size lands at the same concentration. Direct the water against the glass wall, not into the cake, and rotate the vial slowly. Foam means it was shaken, which is worth avoiding.
What sizes does semaglutide come in?
Three: 10mg, 20mg and 30mg, all the same peptide at the same purity. We do not stock a semaglutide 5mg vial, so the 10mg is the smallest working unit in the catalogue; reconstituted at 1mL it gives 10mg/mL. Larger vials bring the per-milligram figure down and suit longer laboratory runs. Multi-vial pack pricing is shown in the pack options.
How should semaglutide be stored?
Lyophilized and sealed at -20C, away from light and moisture. Ambient transit temperatures do not damage freeze-dried peptide. Once reconstituted, keep the vial at 2 to 8C, swab the stopper before each withdrawal, and use the solution within a few weeks. Repeated freeze-thaw cycles on solution are what degrade it fastest.
Semaglutide vs tirzepatide for comparative research?
Semaglutide engages the GLP-1 receptor alone. Tirzepatide engages both GLP-1 and GIP receptors, and retatrutide adds glucagon receptor activity as well. Comparative binding, signalling and pharmacokinetic studies typically run all three in parallel precisely because their receptor coverage differs in a stepwise way.
How is semaglutide shipped?
Blank Peptides ships from inside the USA, with a processing time within 1 business day and tracking emailed at label creation. Outer packaging is plain and carries no compound names. Vials ship padded against impact. Damaged glass gets replaced once support sees photos of the vial and the box.
Is research semaglutide the same as a prescription product?
No, and it should not be treated as one. This material is an unapproved research chemical sold for laboratory use, not a drug, not a supplement, and not for human or veterinary administration. It carries no FDA approval in this form. Ordering confirms you are a qualified researcher using it in a research setting.